About N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide
N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide (PubChem CID 74239494) has the molecular formula C17H21N7O2
and a molecular weight of 355.40 g/mol. Its IUPAC name is N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide.
Molecular Properties
| Compound Name | N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide |
| PubChem CID | 74239494 |
| Molecular Formula | C17H21N7O2 |
| Molecular Weight | 355.40 g/mol |
| Exact Mass | 355.18 |
| IUPAC Name | N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide |
| SMILES | CC(C)Cc1noc(C(C)NC(=O)c2ccc(Cn3cnnn3)cc2)n1 |
| InChI | InChI=1S/C17H21N7O2/c1-11(2)8-15-20-17(26-21-15)12(3)19-16(25)14-6-4-13(5-7-14)9-24-10-18-22-23-24/h4-7,10-12H,8-9H2,1-3H3,(H,19,25) |
| InChIKey | ATAJAHUXTKALAQ-UHFFFAOYSA-N |
| XLogP | 1.79 |
| TPSA | 111.62 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 26 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
| MW ≤ 500 | 355.40 |
| LogP ≤ 5 | 1.79 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide?
The IUPAC name of N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide (CID 74239494) is N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide.
What is the SMILES notation for N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide?
The canonical SMILES for N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide is CC(C)Cc1noc(C(C)NC(=O)c2ccc(Cn3cnnn3)cc2)n1.
What is the InChIKey of N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide?
The InChIKey is ATAJAHUXTKALAQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H21N7O2/c1-11(2)8-15-20-17(26-21-15)12(3)19-16(25)14-6-4-13(5-7-14)9-24-10-18-22-23-24/h4-7,10-12H,8-9H2,1-3H3,(H,19,25).
What are the key properties of N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide?
N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide has a molecular weight of 355.40 g/mol, XLogP of 1.79, 7 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[1-[3-(2-methylpropyl)-1,2,4-oxadiazol-5-yl]ethyl]-4-(tetrazol-1-ylmethyl)benzamide is sourced from PubChem (CID 74239494), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).